1
Total Neurons
Right: 0 | Left: 1
log ratio : inf
log ratio : inf
1,577
Total Synapses
Post: 626 | Pre: 951
log ratio : 0.60
log ratio : 0.60
1,577
Mean Synapses
Post: 626 | Pre: 951
log ratio : 0.60
log ratio : 0.60
ACh(100.0% CL)
Neurotransmitter
Neuron Visualization ⧉
Dark Light
Navigation
- 🖱️ Left Mouse Button (LMB) + Drag
- Rotate the view.
- Shift + 🖱️ LMB + Drag
- Translate the view.
- Ctrl + Mousewheel
- Zoom in and out.
- ⌨️ z
- Reset view to closest
- ⌨️ o
- Toggle between orthographic and perspective projection.
- ⌨️ l
- Reassign random colors to neurons and ROI meshes.
Filtering
- 1
- Use text to filter neurons by type name.
- 2
- Use tags to require or exclude neurons of certain properties, e.g. `soma_side`.
- 3
- Add / remove matched neurons from view.
- 4
- Remove currently selected neurons from view.
- 5
- Toggle individual neurons from view.
ROI Innervation (11 ROIs)
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| CRE_L | 148 | 23.6% | 1.42 | 395 | 41.5% |
| MB_ML_L | 129 | 20.6% | 0.83 | 229 | 24.1% |
| MB_PED_L | 113 | 18.1% | 0.73 | 188 | 19.8% |
| MB_CA_L | 116 | 18.5% | -1.57 | 39 | 4.1% |
| SMP_L | 26 | 4.2% | 1.11 | 56 | 5.9% |
| SLP_L | 27 | 4.3% | -0.95 | 14 | 1.5% |
| PLP_L | 19 | 3.0% | -0.79 | 11 | 1.2% |
| SCL_L | 19 | 3.0% | -1.66 | 6 | 0.6% |
| LH_L | 18 | 2.9% | -1.85 | 5 | 0.5% |
| ICL_L | 10 | 1.6% | -0.74 | 6 | 0.6% |
| ATL_L | 1 | 0.2% | 1.00 | 2 | 0.2% |
Connectivity
Inputs
| upstream partner | # | NT | conns KCg-s3 | % In | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 53 | ACh | 118 | 20.4% | 0.7 |
| LHPV3c1 (L) | 1 | ACh | 71 | 12.3% | 0.0 |
| KCg-m (L) | 45 | ACh | 67 | 11.6% | 1.6 |
| KCg-s3 (L) | 1 | ACh | 40 | 6.9% | 0.0 |
| KCg-s2 (L) | 1 | ACh | 39 | 6.7% | 0.0 |
| PAM08 (L) | 12 | DA | 25 | 4.3% | 0.8 |
| APL (L) | 1 | GABA | 24 | 4.1% | 0.0 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 21 | 3.6% | 0.0 |
| PAM05 (L) | 6 | DA | 15 | 2.6% | 0.7 |
| KCapbp-ap1 (L) | 12 | ACh | 15 | 2.6% | 0.3 |
| VP5+Z_adPN (L) | 1 | ACh | 11 | 1.9% | 0.0 |
| aMe20 (L) | 1 | ACh | 9 | 1.6% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 9 | 1.6% | 0.0 |
| CB2602 (L) | 1 | ACh | 9 | 1.6% | 0.0 |
| PAM07 (L) | 4 | DA | 9 | 1.6% | 0.5 |
| KCg-s1 (L) | 1 | ACh | 8 | 1.4% | 0.0 |
| PAM08 (R) | 2 | DA | 8 | 1.4% | 0.5 |
| SMP146 (R) | 1 | GABA | 7 | 1.2% | 0.0 |
| KCab-p (L) | 7 | ACh | 7 | 1.2% | 0.0 |
| PPL103 (L) | 1 | DA | 5 | 0.9% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 4 | 0.7% | 0.0 |
| MBON04 (R) | 1 | Glu | 4 | 0.7% | 0.0 |
| PPL103 (R) | 1 | DA | 3 | 0.5% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| CL063 (L) | 1 | GABA | 3 | 0.5% | 0.0 |
| DPM (L) | 1 | DA | 3 | 0.5% | 0.0 |
| PAM05 (R) | 2 | DA | 3 | 0.5% | 0.3 |
| MBON26 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| SLP438 (L) | 1 | Unk | 2 | 0.3% | 0.0 |
| PPL101 (L) | 1 | DA | 2 | 0.3% | 0.0 |
| CB1901 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| M_l2PNl23 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| M_l2PNm16 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| FR1 (R) | 1 | Unk | 1 | 0.2% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.2% | 0.0 |
| WED092c (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP142,SMP145 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| CRE060,CRE067 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL135 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP120,PLP145 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PAM12 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| CB2122 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP115_a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| MBON05 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP457 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| OA-ASM2 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| VP4_vPN (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SMPp&v1B_H01 (R) | 1 | 5-HT | 1 | 0.2% | 0.0 |
| PPL202 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| IB116 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| MBON11 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LAL198 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL007 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL228,SMP491 (L) | 1 | Unk | 1 | 0.2% | 0.0 |
| PPL203 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| MBON22 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
Outputs
| downstream partner | # | NT | conns KCg-s3 | % Out | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 48 | ACh | 95 | 15.8% | 0.7 |
| KCg-m (L) | 51 | ACh | 77 | 12.8% | 0.9 |
| KCg-s3 (L) | 1 | ACh | 40 | 6.6% | 0.0 |
| KCg-s2 (L) | 1 | ACh | 36 | 6.0% | 0.0 |
| MBON05 (R) | 1 | Glu | 27 | 4.5% | 0.0 |
| APL (L) | 1 | GABA | 26 | 4.3% | 0.0 |
| PAM08 (L) | 13 | DA | 26 | 4.3% | 0.5 |
| MBON33 (L) | 1 | ACh | 23 | 3.8% | 0.0 |
| MBON04 (R) | 1 | Glu | 21 | 3.5% | 0.0 |
| DPM (L) | 1 | DA | 18 | 3.0% | 0.0 |
| MBON26 (L) | 1 | ACh | 15 | 2.5% | 0.0 |
| MBON11 (L) | 1 | GABA | 15 | 2.5% | 0.0 |
| KCapbp-ap1 (L) | 12 | ACh | 13 | 2.2% | 0.3 |
| KCab-p (L) | 10 | ACh | 11 | 1.8% | 0.3 |
| PAM05 (L) | 3 | DA | 10 | 1.7% | 1.0 |
| PAM08 (R) | 5 | DA | 10 | 1.7% | 0.5 |
| PPL103 (L) | 1 | DA | 8 | 1.3% | 0.0 |
| CRE080c (L) | 2 | ACh | 7 | 1.2% | 0.7 |
| PAM07 (L) | 4 | DA | 7 | 1.2% | 0.2 |
| LHPD5d1 (L) | 1 | ACh | 6 | 1.0% | 0.0 |
| MBON27 (L) | 1 | ACh | 6 | 1.0% | 0.0 |
| MBON32 (L) | 1 | GABA | 6 | 1.0% | 0.0 |
| MBON35 (L) | 1 | ACh | 5 | 0.8% | 0.0 |
| PPL101 (L) | 1 | DA | 5 | 0.8% | 0.0 |
| PPL103 (R) | 1 | DA | 4 | 0.7% | 0.0 |
| KCg-s1 (L) | 1 | ACh | 4 | 0.7% | 0.0 |
| PPL101 (R) | 1 | DA | 4 | 0.7% | 0.0 |
| MBON22 (L) | 1 | ACh | 4 | 0.7% | 0.0 |
| CRE001 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| MBON21 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| CRE080b (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CB1251 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| MBON22 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| CRE105 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| PAM05 (R) | 1 | DA | 2 | 0.3% | 0.0 |
| PPL102 (R) | 1 | DA | 2 | 0.3% | 0.0 |
| MBON12 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| MBON03 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| PAM06 (L) | 1 | DA | 2 | 0.3% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| PAM07 (R) | 2 | DA | 2 | 0.3% | 0.0 |
| aMe26 (L) | 2 | ACh | 2 | 0.3% | 0.0 |
| LAL002 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MBON30 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| CRE023 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CRE070 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CRE060,CRE067 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CRE025 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| FB5V (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PAM02 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| MBON09 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| PAM15 (R) | 1 | DA | 1 | 0.2% | 0.0 |
| MBON09 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| IB049 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CRE060,CRE067 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB0951 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB2987 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP457 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| FB1H (L) | 1 | DA | 1 | 0.2% | 0.0 |
| LHPV6c1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP114 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CRE081 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CRE024 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1976 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SMP504 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP129 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHPV2a1_c (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LAL129 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| FB4O (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB4233 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PAM14 (L) | 1 | Unk | 1 | 0.2% | 0.0 |
| LC28a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP146 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| CRE022 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| FB4C (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CRE049 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MBON29 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL127 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| VC5_lvPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PAM12 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| SMP567 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| FB4F_a,FB4F_b,FB4F_c (L) | 1 | Glu | 1 | 0.2% | 0.0 |